NVNO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.00%

Insider Buying (Last 12 Months): $50,288.60

Insider Selling (Last 12 Months): $4,067.00

enVVeno Medical Insider Trading History Chart

enVVeno Medical Share Price & Price History

^$0.39

▼ -0.0054 (-1.37%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

enVVeno Medical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/15/2025	Francis Duhay	Director	Sell	4,900	$0.83	$4,067.00	97,444
12/31/2024	Robert Gray	Director	Buy	3,500	$2.94	$10,290.00	11,155
12/24/2024	Sanjay Shrivastava	Director	Buy	5,400	$2.90	$15,660.00	9,288
12/19/2024	Matthew Jenusaitis	Director	Buy	9,620	$2.53	$24,338.60	16,545
3/13/2024	Hamed Alavi	CTO	Sell	8,334	$6.22	$51,837.48

SEC Filings (Institutional Ownership Changes) for enVVeno Medical (NASDAQ:NVNO)

34.71% of enVVeno Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

enVVeno Medical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/17/2025	Kingdon Capital Management L.L.C.	1,359,261	$1.23M	0.2%	+58.2%	6.724%
11/13/2025	CM Management LLC	600,000	$0.54M	0.5%	N/A	2.968%
11/4/2025	Westside Investment Management Inc.	212,800	$0.19M	0.0%	-23.9%	1.106%
8/15/2025	Perceptive Advisors LLC	1,284,966	$5.13M	0.5%	N/A	6.675%
8/14/2025	Jane Street Group LLC	12,833	$51K	0.0%	N/A	0.067%
8/14/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	241,161	$0.96M	0.0%	-18.5%	1.253%
8/12/2025	XTX Topco Ltd	17,627	$70K	0.0%	-42.1%	0.092%
8/12/2025	JPMorgan Chase & Co.	182,300	$0.73M	0.0%	-6.1%	0.947%
8/11/2025	Universal Beteiligungs und Servicegesellschaft mbH	200,000	$0.80M	0.0%	N/A	1.039%
8/8/2025	Creative Planning	13,500	$54K	0.0%	N/A	0.070%
8/8/2025	Geode Capital Management LLC	199,509	$0.80M	0.0%	+1.1%	1.036%
8/5/2025	Westside Investment Management Inc.	279,525	$1.12M	0.2%	+7.9%	1.594%
5/13/2025	Altium Capital Management LLC	123,256	$0.32M	0.8%	-60.2%	0.703%
5/8/2025	XTX Topco Ltd	30,437	$80K	0.0%	N/A	0.174%
5/7/2025	Dauntless Investment Group LLC	70,848	$0.19M	0.2%	N/A	0.404%
5/2/2025	Hohimer Wealth Management LLC	20,000	$53K	0.0%	-61.0%	0.114%
4/25/2025	Westside Investment Management Inc.	259,050	$0.68M	0.1%	+26.4%	1.477%
2/17/2025	Alyeska Investment Group L.P.	209,180	$0.63M	0.0%	-50.8%	1.193%
2/14/2025	Jane Street Group LLC	18,502	$56K	0.0%	N/A	0.105%
2/14/2025	Northern Trust Corp	56,725	$0.17M	0.0%	+68.3%	0.323%
2/14/2025	Dimensional Fund Advisors LP	16,242	$49K	0.0%	-51.1%	0.093%
2/14/2025	Altium Capital Management LLC	310,000	$0.94M	0.3%	+29.8%	1.767%
2/13/2025	Marshall Wace LLP	48,818	$0.15M	0.0%	N/A	0.278%
2/12/2025	Geode Capital Management LLC	181,737	$0.55M	0.0%	+20.6%	1.036%
2/12/2025	National Bank of Canada FI	20,000	$60K	0.0%	N/A	0.114%
2/12/2025	JPMorgan Chase & Co.	270,041	$0.82M	0.0%	N/A	1.540%
2/11/2025	Virtu Financial LLC	28,533	$86K	0.0%	N/A	0.163%
1/31/2025	Sanctuary Advisors LLC	12,000	$39K	0.0%	N/A	0.068%
1/17/2025	Westside Investment Management Inc.	205,025	$0.62M	0.1%	+132.0%	1.169%
1/15/2025	Fermata Advisors LLC	35,706	$0.11M	0.0%	+18.1%	0.204%
11/20/2024	Westside Investment Management Inc.	88,375	$0.30M	0.1%	+128.0%	0.504%
11/19/2024	Hohimer Wealth Management LLC	85,000	$0.29M	0.1%	N/A	0.485%
11/16/2024	Geode Capital Management LLC	150,676	$0.51M	0.0%	+7.8%	0.859%
11/15/2024	Maven Securities LTD	87,880	$0.30M	0.0%	N/A	0.501%
11/14/2024	Corsair Capital Management L.P.	116,000	$0.39M	0.1%	N/A	0.661%
8/20/2024	Nantahala Capital Management LLC	477,855	$2.51M	0.1%	-3.6%	3.585%
7/17/2024	Westside Investment Management Inc.	38,762	$0.20M	0.0%	+933.7%	0.291%
7/13/2024	Fermata Advisors LLC	30,949	$0.16M	0.0%	+33.4%	0.232%
5/16/2024	Kingdon Capital Management L.L.C.	653,870	$3.56M	0.4%	+5.6%	4.905%
5/15/2024	Quadrature Capital Ltd	18,872	$0.10M	0.0%	N/A	0.142%
5/10/2024	Acadian Asset Management LLC	6,825	$37K	0.0%	N/A	0.051%
5/10/2024	Vanguard Group Inc.	573,955	$3.12M	0.0%	+70.6%	4.310%
5/3/2024	RIA Advisory Group LLC	43,666	$0.24M	0.1%	N/A	0.328%
5/1/2024	Janney Montgomery Scott LLC	34,140	$0.19M	0.0%	N/A	0.256%
4/12/2024	Fermata Advisors LLC	23,198	$0.13M	0.0%	+42.1%	0.174%
3/18/2024	Kingdon Capital Management L.L.C.	619,180	$3.18M	0.4%	+182.5%	4.648%
2/26/2024	Perceptive Advisors LLC	623,315	$3.20M	0.1%	-20.3%	4.680%
2/13/2024	Armistice Capital LLC	436,000	$2.24M	0.0%	N/A	3.273%
1/19/2024	Fermata Advisors LLC	16,325	$84K	0.0%	+37.8%	0.123%
11/7/2023	Fermata Advisors LLC	11,850	$64K	0.0%	N/A	0.089%
7/19/2023	Arthur M. Cohen & Associates LLC	14,000	$43K	0.0%	-41.7%	0.148%
11/14/2022	UBS Oconnor LLC	149,720	$0.94M	0.0%	+26.8%	1.581%
7/26/2022	Sepio Capital LP	10,800	$41K	0.0%	N/A	0.114%
7/18/2022	Arthur M. Cohen & Associates LLC	24,000	$91K	0.0%	+60.0%	0.253%
5/11/2022	ACT Capital Management LLC	401,200	$2.56M	2.7%	+52.8%	4.237%
2/15/2022	Kingdon Capital Management L.L.C.	219,180	$1.44M	0.2%	N/A	2.315%
2/14/2022	Perceptive Advisors LLC	781,615	$5.15M	0.1%	N/A	8.255%
2/3/2022	ACT Capital Management LLC	262,500	$1.73M	1.3%	N/A	2.772%
1/24/2022	Arthur M. Cohen & Associates LLC	14,000	$92K	0.0%	N/A	0.148%
8/16/2021	State Street Corp	20,200	$0.14M	0.0%	N/A	0.237%

Data available starting January 2016

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.

Today's Range

Now: $0.39

$0.37

$0.40

50 Day Range

MA: $0.65

$0.32

$0.97

52 Week Range

Now: $0.39

$0.30

$5.62

Volume

244,634 shs

Average Volume

898,221 shs

Market Capitalization

$7.85 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.06

Who are the company insiders with the largest holdings of enVVeno Medical?: enVVeno Medical's top insider investors include:
Francis Duhay (Director)
Matthew Jenusaitis (Director)
Robert Gray (Director)
Sanjay Shrivastava (Director)
Hamed Alavi (CTO)
Learn More about top insider investors at enVVeno Medical.
Who are the major institutional investors of enVVeno Medical?: enVVeno Medical's top institutional investors include:
Kingdon Capital Management L.L.C. — 6.72%
CM Management LLC — 2.97%
Westside Investment Management Inc. — 1.11%
Citadel Advisors LLC — 0.00%
Learn More about top institutional investors of enVVeno Medical stock.
Which institutional investors are selling enVVeno Medical stock?: Within the previous quarter, NVNO stock was sold by these institutional investors:
Westside Investment Management Inc.
Which institutional investors are buying enVVeno Medical stock?: Within the last quarter, NVNO stock was acquired by institutional investors including:
CM Management LLC
Kingdon Capital Management L.L.C.
Citadel Advisors LLC
Within the previous year, these company insiders have bought enVVeno Medical stock:
Francis Duhay (Director)
Matthew Jenusaitis (Director)
Robert Gray (Director)
Learn More investors buying enVVeno Medical stock.